◆英語タイトル:Evotec AG (EVT) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA8011094
◆発行会社(調査会社):
GlobalData
◆発行日:2017年12月21日
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:ドイツ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
※
販売価格オプションの説明はこちらで、
ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
※
GlobalData社の概要はこちらでご確認いただけます。
【レポートの概要】
Summary
Evotec AG (Evotec) is a drug discovery alliance and development partnership company. It identifies and develops small molecule drugs across various therapeutic areas such as, cancer, neurological and nephrological conditions, cardiovascular, inflammation, pain, metabolic and respiratory diseases. Evotec provides services such as integrated services, assay development and screening, reagent production services, ADMET, cellular target profiling, vitro pharmacology services and proteomics services. The company has long-term discovery alliances with several leading pharmaceutical companies and also has development partnerships for product candidates in clinical and pre-clinical development stages. The company has operating facilities in Abingdon and Manchester, the UK; Gottingen and Munich, Germany; South San Francisco, Branford and Princeton, the US; and Toulouse, France. Evotec is headquartered in Hamburg, Germany.
Evotec AG (EVT) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.
Scope
- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.
Reasons to Buy
Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.
Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.
Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Evotec AG, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Evotec AG, Medical Equipment Deals By Type, 2011 to YTD 2017 6
Evotec AG, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Evotec AG, Medical Equipment, Deals By Market, 2011 to YTD 2017 8
Evotec AG, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Evotec AG, Medical Equipment, Deal Details 10
Partnerships 10
Evotec Enters into Partnership with University of Bristol, University of Cambridge and Mario Negri Institute for Pharmacological Research 10
Evotec Enters Into Co-Development Agreement With Probiodrug For Glutaminyl Cyclase 12
Cyprotex Enters Into Agreement With InSphero For New 3D Microtissue Service 13
Roche Enters Into Collaboration With Evotec 14
Cyprotex Enters Into Licensing Agreement With Sigma For Zinc Finger Nuclease Technology 15
Acquisition 16
Evotec Acquires Cyprotex for USD68 Million 16
Apredica Acquires CeeTox, In-Vitro Toxicological Assays And Screening Data Provider, For Up To US$6 Million 18
Evotec AG – Key Competitors 19
Evotec AG – Key Employees 20
Evotec AG – Locations And Subsidiaries 21
Head Office 21
Other Locations & Subsidiaries 21
Joint Venture 22
Recent Developments 23
Strategy And Business Planning 23
Jan 26, 2017: Cyprotex, an Evotec Company, Expands into New UK Facility at Alderley Park 23
Other Significant Developments 24
Jun 28, 2016: Genedata Announces Evotec Selects Genedata Screener as its Screening Platform 24
Appendix 25
Methodology 25
About GlobalData 25
Contact Us 25
Disclaimer 25
List of Tables
Evotec AG, Medical Equipment, Key Facts, 2016 2
Evotec AG, Medical Equipment, Deals Summary, 2011 to YTD 2017 2
Evotec AG, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Evotec AG, Medical Equipment Deals By Type, 2011 to YTD 2017 6
Evotec AG, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Evotec AG, Deals By Market, 2011 to YTD 2017 8
Evotec AG, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Evotec Enters into Partnership with University of Bristol, University of Cambridge and Mario Negri Institute for Pharmacological Research 10
Evotec Enters Into Co-Development Agreement With Probiodrug For Glutaminyl Cyclase 12
Cyprotex Enters Into Agreement With InSphero For New 3D Microtissue Service 13
Roche Enters Into Collaboration With Evotec 14
Cyprotex Enters Into Licensing Agreement With Sigma For Zinc Finger Nuclease Technology 15
Evotec Acquires Cyprotex for USD68 Million 16
Apredica Acquires CeeTox, In-Vitro Toxicological Assays And Screening Data Provider, For Up To US$6 Million 18
Evotec AG, Key Competitors 19
Evotec AG, Key Employees 20
Evotec AG, Subsidiaries 21
Evotec AG, Joint Venture 22